SOX9 and cancer: Absent or reduced SOX9 expression was strongly linked to biochemical (PSA) recurrence in the subset of ERG-positive cancers (p<0.0001, Fig 4A), but not in ERG-negative cancers (p = 0.80, Fig 4B).